Product Information

DILTIAZEM 24H ER(CD) 300 MG CP is a generic product labeled by Endo USA Inc., priced at $0.3005 per EA under NDC 10370083209. Its NADAC has been published 476 times since Jul 12, 2017.

FDA first approved this application on Dec 20, 1999. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DILTIAZEM 24H ER(CD) 300 MG CP

Diltiazem Hydrochloride
$0.3005per EA

Strength

300 mg/1

Manufacturer

Endo USA Inc.

NDC

10370083209

Classification

Generic

Dosage Form

CAPSULE, COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DILTIAZEM HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA074984

FDA Approved

12/20/1999

TE Code

AB3

On Market Since

10/1/2015

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A4 Inhibitors

Price Statistics

The NADAC for DILTIAZEM 24H ER(CD) 300 MG CP has been published 476 times since Jul 12, 2017, and over the history we have for it it has declined 53.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3005 per EA
All-time high$0.6510 (Oct 11, 2017)
All-time low$0.2613 (Apr 19, 2023)
52-week high$0.3098
52-week low$0.2943
Median price$0.3840
Average price$0.4111
Largest weekly change+35.3% (Aug 21, 2024)
Weeks tracked476
Tracking sinceJul 12, 2017

Price History

1W

+2.1%

1M

+0.7%

3M

-0.7%

6M

-2.8%

1Y

-1.1%

3Y

+2.5%

5Y

-24.3%

All

-53.5%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 42% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DILTIAZEM 24H ER(CD) 300 MG CP?

The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 24H ER(CD) 300 MG CP, manufactured by Endo USA Inc., is $0.3005 per EA (NDC 10370083209), effective Aug 19, 2026.

How has the price of DILTIAZEM 24H ER(CD) 300 MG CP changed over time?

Over the history we have for it, the NADAC for DILTIAZEM 24H ER(CD) 300 MG CP has declined 53.5%. It has been tracked across 476 weekly CMS publications since Jul 12, 2017.

What are the highest and lowest recorded NADAC prices for DILTIAZEM 24H ER(CD) 300 MG CP?

Since Jul 12, 2017, the NADAC for DILTIAZEM 24H ER(CD) 300 MG CP has ranged from a low of $0.2613 (Apr 19, 2023) to a high of $0.6510 (Oct 11, 2017), with a median of $0.3840 per EA.

Are there cheaper alternatives to DILTIAZEM 24H ER(CD) 300 MG CP?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DILTIAZEM 24HR ER 300 MG CAP, is $0.1729 per EA — about 42% below DILTIAZEM 24H ER(CD) 300 MG CP.

Who manufactures DILTIAZEM 24H ER(CD) 300 MG CP?

DILTIAZEM 24H ER(CD) 300 MG CP (NDC 10370083209) is labeled by Endo USA Inc., and CMS classifies it as a generic product.